OS Therapies Incorporated
Organization details
- Legal name
- OS Therapies Incorporated
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Rockville
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OSTX
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001795091
- EIN
- 82-5118368
Board of directors
-
Avril Suzette McKean-Dieser · DirectorSince 2024
-
Colin Goddard · DirectorSince 2024
-
Craig Eagle · DirectorSince 2026
-
Joacim Borg · DirectorSince 2024
-
John Ciccio · DirectorSince 2024
-
Karim Galzahr · DirectorSince 2025
-
Olivier Roger Jarry · DirectorSince 2024
-
Paul A. Romness · Director · President and CEOSince 2024
-
Theodore F. Search · DirectorSince 2024
Chief executives
Director election results
Annual meeting of September 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.0%
-
99.1%
-
99.1%
-
99.1%
-
99.1%
-
99.1%
Board connections
1 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
Q/C Technologies Inc. Same sectorvia Craig Eagle
-
Telomir Pharmaceuticals Inc. Same sectorvia Craig Eagle
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 7, 2025 | Auerbach Shalom 10% owner | Open-market sale | −82,000 | $2.00 | $164,000 |
| Apr 10, 2025 | Auerbach Shalom 10% owner | Open-market sale | −10,000 | $1.39 | $13,900 |
| Apr 9, 2025 | Auerbach Shalom 10% owner | Open-market sale | −50,012 | $1.35 | $67,516 |
| Feb 28, 2025 | Paul A. Romness Director, Officer (President and CEO), 10% owner | Other | +225,000 | — | — |
| Feb 27, 2025 | Einodmil LLC 10% owner | Other | −225,000 | $1.64 | $369,000 |
| Feb 14, 2025 | Einodmil LLC 10% owner | Open-market sale | −100,000 | $2.84 | $284,000 |
| Jan 15, 2025 | Auerbach Shalom 10% owner | Open-market sale | −16,720 | $6.74 | $112,693 |
| Aug 2, 2024 | Theodore F. Search Director | Derivative conversion | +101,765 | — | — |
| Aug 2, 2024 | John Ciccio Director | Derivative conversion | +101,765 | — | — |
| Aug 2, 2024 | Auerbach Shalom 10% owner | Derivative conversion | +23,371 | — | — |
| Aug 2, 2024 | Theodore F. Search Director | Derivative conversion | +266,306 | — | — |
| Aug 2, 2024 | John Ciccio Director | Derivative conversion | +266,306 | — | — |
| Aug 2, 2024 | Auerbach Shalom 10% owner | Derivative conversion | +633,980 | — | — |
| Aug 2, 2024 | Theodore F. Search Director | Derivative conversion | +30,264 | — | — |
| Aug 2, 2024 | John Ciccio Director | Derivative conversion | +30,264 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about OS Therapies Incorporated
Who is the CEO of OS Therapies Incorporated?
Paul A. Romness has been OS Therapies Incorporated's President and CEO since July 2024.
How many directors are on OS Therapies Incorporated's board?
OS Therapies Incorporated's board has 9 directors: Avril Suzette McKean-Dieser, Colin Goddard, Craig Eagle, Joacim Borg, John Ciccio, Karim Galzahr, Olivier Roger Jarry, Paul A. Romness and Theodore F. Search.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="os-therapies-incorporated"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.